VIDAS® HIV Panel
Advanced 4th Generation Assays for Earlier Diagnosis
The VIDAS® HIV panel provides a combination of advanced 4th generation assays for improved detection of acute HIV during the critical “window period”.
Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.
- Overview
- Assays
- Resources
Overview
Many of the 35.3 million people infected with HIV worldwide are unaware of their condition, as symptoms may be absent or non-specific. In addition, there is a mean period of 3 weeks between contamination and the appearance of the first anti-HIV serum antibodies1. Early detection of seroconversions is thus one of the main HIV diagnostic challenges.
The VIDAS® automated HIV infection screening tests allow simultaneous detection of p24 antigen and anti-HIV antibodies enabling the time lapse between contamination and diagnosis of the infection to be decreased. Identifying more primary infections can make a key difference in reducing transmission. Providing appropriate therapy as fast as possible is also essential to improve patient outcome.
A Unique Assay Concept
- Combined detection of anti-HIV-1 (groups M and O) and anti-HIV-2 total immunoglobulins + HIV-1 p24 antigen
- True dual information: differentiation of Ag and Ab signals
- Highest p24 Ag sensitivity currently available
Assay Concept:
Excellent Performances
- Best analytical sensitivity compared to other commonly-used assays2,3
- Lowest limit of detection of HIV infection2,3
- Highest p24 Ag sensitivity currently available (Lower Limit of Detection against the WHO standard):
- VIDAS® HIV Duo Ultra: 0.66 IU/mL3
- VIDAS® HIV Duo Quick: 0.43 IU/mL3
- VIDAS® HIV P24:0.73 - 1.15 IU/mL3
Ease of Use and Flexibility for Your Lab
- Easy-to-use solution
- One patient, one strip
- Renowned VIDAS® robustness and reliability
VIDAS® SOLUTION
- Reliable and easy-to-use instruments with random access and small footprint. Well adapted to rapid response laboratories
- Factory-calibrated, single-dose tests which reduce the need for additional controls
- Short time to result
- Reagents can be used immediately after removal from the refrigerator
References:
1Kleinman S., et al. Transfusion Medicine Reviews. July 1997. Vol. 11, N° 3 p. 155-172.
2Ly TD, et al. 2007 Jul; 143(1):86-94. Epub 2007 Mar 28.
3Miedouge M, et al. J Clin Virol. 2011 Jan;50(1):57-60. doi: 10.1016/j.jcv.2010.09.003.
Assays
Technical Specifications
| Assay | Reference | Code | Time to Result | Measurement Range or Interpretation |
|---|---|---|---|---|
| HIV DUO Ultra | 30443 | HIV5 | ||
| HIV DUO Quick | 30447 | HIV6 | ||
| P24 II | 30117 | P24 | ||
| HIV P24 II Confirmation | 30444 |
BECAUSE IT MAKES SENSE ON VIDAS®
Resources
Related Publications
- Ly TD, Ebel A, Faucher V, Fihman V, Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J Virol Methods. 2007 Jul;143(1):86-94. Epub 2007 Mar 28.
- Miedouge M, Grèze M, Bailly A, Izopet J. Analytical sensitivity of four HIV combined antigen/antibody assays using the p24 WHO standard. J Clin Virol. 2011 Jan;50(1):57-60. doi: 10.1016/j.jcv.2010.09.003.
